TF2L1 Polyclonal Antibody

Transcriptional suppressor. May suppress UBP1-mediated transcriptional activation. Modulates the placental expression of CYP11A1.,Belongs to the grh/CP2 family. CP2 subfamily.,tissue specificity:Highly expressed in placental JEG-3 cells and very low levels of expression in non-steroidogenic cells. No expression was seen in adrenal NCI-H295A cells or in adrenal tissue.,

The TF2L1 polyclonal antibody is a highly specific and reliable tool for the detection and analysis of TF2L1 protein expression. This antibody has been meticulously developed and rigorously validated to ensure optimal performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

With its exceptional affinity and sensitivity, the TF2L1 polyclonal antibody enables accurate and precise identification of TF2L1 protein in a wide range of samples. It exhibits minimal cross-reactivity with other proteins, ensuring reliable and specific results.

The TF2L1 polyclonal antibody is produced using state-of-the-art techniques, guaranteeing batch-to-batch consistency and high purity. It has been extensively tested on multiple cell lines and tissues, demonstrating its robustness and reliability.

This antibody is supplied in a convenient and user-friendly format, allowing for easy handling and storage. It is provided in a liquid form, ready for immediate use, eliminating the need for time-consuming reconstitution.

Whether you are conducting basic research, drug discovery, or clinical diagnostics, the TF2L1 polyclonal antibody is an indispensable tool for investigating TF2L1 protein expression. Its exceptional performance and reliability make it an ideal choice for scientists and researchers in the field.